Classification of Pancreatic Cancer and Normal Tissue in 2D and 3D Optical Coherence Tomography Images Using Convolutional Neural Networks: A Comparative Study

Read full text Summarise with VIRAT
Authors: Mariia Druzenko, Bastian Westerheide, Caroline Girmen, Niels König, Robert Schmitt, Svetlana Warkentin, K. Jöchle, Sebastian Cammann, Georg J. Wiltberger, Martin W. von Websky, Thomas Vogel, Florian Vondran
+2 more Iakovos Amygdalos, :unav
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background/Objectives: Early and complete (R0) surgical resection is essential for optimal outcomes in pancreatic cancer. Optical coherence tomography (OCT) combined with artificial intelligence (AI) may offer real-time intraoperative guidance, potentially reducing reliance on frozen sections. This ex vivo study evaluated convolutional neural networks (CNNs) for distinguishing pancreatic ductal adenocarcinoma (PDAC) from normal pancreatic tissue in OCT images obtained ex vivo. Methods: Between October 2020 and April 2021, OCT scans were obtained from resected pancreatic specimens of 27 adult patients. Tumor and adjacent normal tissue were imaged using a 1310 nm OCT system, followed by histopathological confirmation. A total of 25 PDAC and 30 non-malignant scans were preprocessed and analyzed using cross-validated CNN models (ResNet50, DenseNet121, and MobileNetV2) with both 2D and 3D inputs. Results: Using five-fold stratified cross-validation on 9040 2D and 3000 3D samples (224 px resolution), the 3D DenseNet121 model achieved the highest performance, with an F1-score of 0.74, sensitivity of 72%, and specificity of 81%. Other architectures demonstrated comparable results. Conclusions: AI-assisted OCT can accurately differentiate PDAC from normal pancreatic tissue ex vivo, supporting its potential as a rapid intraoperative diagnostic adjunct. Further studies are warranted to assess its in vivo performance and utility in evaluating resection margins.

Fields of Study & Subjects

AI in cancer detection Radiomics and Machine Learning in Medical Imaging Pancreatic and Hepatic Oncology Research

Publication details

Journal / source
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Publication date
1 January 2026
Language
EN